Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 14, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2025. Go to the latest filing (Q3 2026)

38.5B USDQ3 2025
Total value of stock positions
38.5B USD
Positions
78
Share of the ten largest
33.6%

The ten largest positions Q3 2025

  1. PNC Financial Services 4.2%▲ +234.9%
  2. JPMorgan Chase 4.1%▲ +25.2%
  3. Charles Schwab Corporation 4.1%▲ +5.1%
  4. Capital One 4.1%▲ +30.3%
  5. Microsoft 3.3%new
  6. Walt Disney Company (The) 3.1%▲ +78.7%
  7. Taiwan Semiconductor Manufacturing (ADR) 2.9%▼ −8.9%
  8. Mcdonalds Corp 2.7%▲ +8.0%
  9. Fortive 2.6%▲ +28.7%
  10. Air Products 2.6%▲ +70.2%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q3 2025

Positions Q3 2025 per 13F filing, 50 of 78
Symbol Weight Shares Reported value Change Held since
Bridgebio Pharma Inc 2.2% 15,977,849 829.9M USD −13.9% reduced Q2 2019 26 quarters
Adaptive Biotechnologies Cor 1.2% 29,993,708 448.7M USD unchanged Q2 2019 26 quarters
FTV Fortive 2.6% 20,483,680 1.0B USD +28.7% increased Q3 2019 25 quarters
Api Group Corp 1.1% 12,306,277 423.0M USD +6.7% increased Q2 2020 22 quarters
Pharvaris N V 0.2% 3,653,310 91.2M USD unchanged Q1 2021 19 quarters
Rallybio Corp < 0.1% 4,194,777 2.1M USD unchanged Q3 2021 17 quarters
Biomarin Pharmaceutical Inc 1.2% 8,322,179 450.7M USD −32.3% reduced Q4 2021 16 quarters
Roivant Sciences Ltd 0.9% 23,594,831 357.0M USD −31.1% reduced Q4 2021 16 quarters
Pepgen Inc < 0.1% 3,482,434 16.1M USD +134.9% increased Q2 2022 14 quarters
Trevi Therapeutics Inc 0.1% 5,128,875 46.9M USD +232.4% increased Q3 2022 13 quarters
CSX CSX Corporation 1.5% 15,947,719 566.3M USD −15.5% reduced Q4 2022 12 quarters
Newamsterdam Pharma Company 0.5% 6,475,534 184.2M USD −7.2% reduced Q4 2022 12 quarters
PM Philip Morris International 1.9% 4,426,128 717.9M USD +28.1% increased Q2 2023 10 quarters
TMUS T-Mobile US 2.0% 3,262,466 781.0M USD +14.7% increased Q4 2023 8 quarters
HCA HCA Healthcare 1.5% 1,380,583 588.4M USD −26.3% reduced Q4 2023 8 quarters
Regal Rexnord Corporation 1.2% 3,123,262 448.0M USD −8.9% reduced Q4 2023 8 quarters
CPT Camden Property Trust 1.1% 3,846,740 410.8M USD +41.6% increased Q1 2024 7 quarters
Integer HLDGS Corp 0.3% 1,024,942 105.9M USD −20.2% reduced Q1 2024 7 quarters
Oric Pharmaceuticals Inc 0.2% 6,572,700 78.9M USD unchanged Q1 2024 7 quarters
Standard Biotools Inc 0.2% 58,651,170 76.2M USD unchanged Q1 2024 7 quarters
JPM JPMorgan Chase 4.1% 5,059,060 1.6B USD +25.2% increased Q2 2024 6 quarters
SHW Sherwin-Williams 2.6% 2,881,091 997.6M USD +47.2% increased Q2 2024 6 quarters
CVNA Carvana 2.1% 2,101,241 792.7M USD +94.9% increased Q2 2024 6 quarters
Inhibrx Biosciences Inc 0.2% 1,787,705 60.2M USD unchanged Q2 2024 6 quarters
SCHW Charles Schwab Corporation 4.1% 16,583,101 1.6B USD +5.1% increased Q3 2024 5 quarters
V Visa Inc. 2.6% 2,897,030 989.0M USD +78.7% increased Q3 2024 5 quarters
BAC Bank of America 1.5% 11,500,290 593.3M USD −63.2% reduced Q3 2024 5 quarters
BSX Boston Scientific 0.7% 2,641,682 257.9M USD −13.3% reduced Q3 2024 5 quarters
Ginkgo Bioworks Holdings Inc 0.1% 3,577,128 52.2M USD unchanged Q3 2024 5 quarters
Teva Pharmaceutical Inds Ltd 0.1% 2,532,119 51.1M USD −78.3% reduced Q3 2024 5 quarters
TSM Taiwan Semiconductor Manufacturing (ADR) 2.9% 3,944,366 1.1B USD −8.9% reduced Q4 2024 4 quarters
GM General Motors 2.1% 13,027,139 794.3M USD +0.1% increased Q4 2024 4 quarters
BA Boeing 1.7% 3,010,551 649.8M USD +6.2% increased Q4 2024 4 quarters
ROST Ross Stores 0.8% 2,023,868 308.4M USD −57.4% reduced Q4 2024 4 quarters
APP AppLovin 0.3% 162,525 116.8M USD −56.4% reduced Q4 2024 4 quarters
COF Capital One 4.1% 7,388,506 1.6B USD +30.3% increased Q1 2025 3 quarters
Mcdonalds Corp 2.7% 3,374,875 1.0B USD +8.0% increased Q1 2025 3 quarters
TSLA Tesla, Inc. 1.9% 1,609,828 715.9M USD +46.3% increased Q1 2025 3 quarters
META Meta Platforms 1.8% 929,003 682.2M USD +249.9% increased Q1 2025 3 quarters
NKE Nike, Inc. 1.6% 8,996,579 627.3M USD +29.1% increased Q1 2025 3 quarters
COR Cencora 1.4% 1,778,135 555.7M USD −14.6% reduced Q1 2025 3 quarters
DHR Danaher Corporation 1.4% 2,751,245 545.5M USD −5.4% reduced Q1 2025 3 quarters
SE Sea Limited (ADR) 1.4% 3,039,203 543.2M USD −14.1% reduced Q1 2025 3 quarters
Primo Brands Corporation 1.3% 23,033,970 509.1M USD +17.5% increased Q1 2025 3 quarters
Acuren Corp 1.2% 34,360,000 457.3M USD unchanged Q1 2025 3 quarters
CMG Chipotle Mexican Grill 0.7% 6,636,563 260.1M USD +16.7% increased Q1 2025 3 quarters
Amer Sports Inc 0.6% 6,343,481 220.4M USD +63.5% increased Q1 2025 3 quarters
FSLR First Solar 0.4% 767,996 169.4M USD −66.1% reduced Q1 2025 3 quarters
Ryan Specialty Holdings Inc 0.3% 1,934,957 109.1M USD +37.0% increased Q1 2025 3 quarters
Sionna Therapeutics Inc 0.2% 3,195,181 94.0M USD unchanged Q1 2025 3 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 longest-held of 78 positions.

Breakdown by sector

  • Financials 24.7%
  • Consumer Discretionary 9.5%
  • Technology 8.8%
  • Communication Services 8.8%
  • Industrials 7.7%
  • Health Care 5.7%
  • Materials 5.2%
  • Real Estate 2.9%
  • Consumer Staples 1.9%
  • not in our coverage 24.8%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close